Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study

被引:6
|
作者
Deconinck, L. [1 ,2 ,5 ]
Yazdanpanah, Y. [2 ,3 ]
Gilson, R. J. [1 ,4 ]
Melliez, H. [5 ]
Viget, N. [5 ]
Joly, V. [3 ]
Sabin, C. A. [1 ]
机构
[1] UCL, UCL Res Dept Infect & Populat Hlth, London, England
[2] Paris Diderot Univ, Decis Sci Infect Dis Prevent Control & Care, IAME, Sorbonne Paris Cite,UMR 1137, Paris, France
[3] Bichat Claude Bernard Hosp, Dept Infect Dis, Paris, France
[4] Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, London, England
[5] Tourcoing Hosp, Lille Sch Med, Dept Infect Dis, Tourcoing, France
关键词
AIDS-related opportunistic infections; antiretroviral therapy; HIV; time to treatment; CONSEQUENCES; AIDS;
D O I
10.1111/hiv.12201
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
ObjectivesThe aim of the study was to identify factors associated with the time between opportunistic disease (OD) diagnosis and antiretroviral therapy (ART) initiation in HIV-infected patients presenting for care with an OD, and to evaluate the outcomes associated with any delay. MethodsA multicentre cohort study was undertaken in London, Paris and Lille/Tourcoing. The medical records of patients diagnosed from 2002 to 2012 were reviewed. ResultsA total of 437 patients were enrolled in the study: 70% were male, the median age was 40 years, 42% were from sub-Saharan Africa, 68% were heterosexual, the median CD4 count was 40cells/L, and the most common ODs were Pneumocystis pneumonia (37%), tuberculosis (24%), toxoplasmosis (12%) and Kaposi's sarcoma (11%). Of these patients, 400 (92%) started ART within 24 weeks after HIV diagnosis, with a median time from OD diagnosis to ART initiation of 30 [interquartile range (IQR) 16-58] days. Patients diagnosed between 2009 and 2012 had a shorter time to ART initiation than those diagnosed in earlier years [hazard ratio (HR) 2.07; 95% confidence interval (CI) 1.58-2.72]. Factors associated with a longer time to ART initiation were a CD4 count200cells/L (HR 0.30; 95% CI 0.20-0.44), tuberculosis (HR 0.40; 95% CI 0.30-0.55) and diagnosis in London (HR 0.62; 95% CI 0.48-0.80). Patients initiating deferred' ART (by 30 days) exhibited no difference in disease progression or immunovirological response compared with patients who had shorter times to ART initiation. Patients in the deferred' group were less likely to have ART modifications (HR 0.69; 95% CI 0.48-1.00) and had shorter in-patient stays (mean 14.2 days shorter; 95% CI 8.9-19.5 days) than patients in the group whose ART was not deferred. ConclusionsThe time between OD diagnosis and ART initiation remains heterogeneous and relatively long, particularly in individuals with a high CD4 count or tuberculosis or those diagnosed in London. Deferring ART was associated with fewer ART modifications and shorter in-patient stays.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 50 条
  • [41] Herpes Zoster Among HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era: Korean HIV Cohort Study
    Song, Joon Young
    Cheong, Hee Jin
    Kim, Woo Joo
    Lee, Jin Soo
    Jung, Moon Hyun
    Jung, Hye Won
    Choi, Hee Jung
    Lee, Jin Seo
    Eom, Joong Shik
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (03) : 417 - 419
  • [42] The burden of anemia among Chinese HIV-infected patients following the initiation of antiretroviral therapy in the treat-all era: a nationwide cohort study
    Lai Wei
    Yan Zhao
    Xiumin Gan
    Decai Zhao
    Yasong Wu
    Zhihui Dou
    Ye Ma
    BMC Infectious Diseases, 23
  • [43] The burden of anemia among Chinese HIV-infected patients following the initiation of antiretroviral therapy in the treat-all era: a nationwide cohort study
    Wei, Lai
    Zhao, Yan
    Gan, Xiumin
    Zhao, Decai
    Wu, Yasong
    Dou, Zhihui
    Ma, Ye
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [44] Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients
    Koek, A.
    Hocqueloux, L.
    Hocini, H.
    Carriere, M.
    Lefrou, L.
    Guguin, A.
    Tisserand, P.
    Bonnabau, H.
    Avettand-Fenoel, V.
    Prazuck, T.
    Katsahian, S.
    Gaulard, P.
    Thiebaut, R.
    Levy, Y.
    Huee, S.
    MUCOSAL IMMUNOLOGY, 2015, 8 (01) : 127 - 140
  • [45] OPPORTUNISTIC INFECTIONS WITH ORAL INJURIES IN HIV-INFECTED PATIENTS BEFORE PRESCRIPTION AND AGAINST THE BACKGROUND OF ANTIRETROVIRAL THERAPY
    Marchenko, K., V
    Koval, T., I
    Marchenko, O. H.
    Dvornyk, V. M.
    WORLD OF MEDICINE AND BIOLOGY, 2021, 78 (04): : 95 - 99
  • [46] Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy
    Soriano, V
    Dona, C
    Rodríguez-Rosado, R
    Barreiro, P
    González-Lahoz, J
    AIDS, 2000, 14 (04) : 383 - 386
  • [47] Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy
    Jubault, V
    Pacanowski, J
    Rabian, C
    Viard, JP
    ANNALES DE MEDECINE INTERNE, 2000, 151 (03): : 163 - 168
  • [48] Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study
    Li, Nan
    Sando, Mary Mwanyika
    Spiegelman, Donna
    Hertzmark, Ellen
    Liu, Enju
    Sando, David
    Machumi, Lameck
    Chalamilla, Guerino
    Fawzi, Wafaie
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (07): : 1057 - 1064
  • [49] Antiretroviral therapy in HIV-infected children
    Fan, Conghai
    Zhang, Fengchao
    Chen, Chao
    MINERVA PEDIATRICA, 2019, 71 (05) : 455 - 460
  • [50] Natural history of opportunistic disease in an HIV-infected urban clinical cohort
    Moore, RD
    Chaisson, RE
    ANNALS OF INTERNAL MEDICINE, 1996, 124 (07) : 633 - +